The global albumin market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The growth of the global albumin market is driven by factors such as increasing prevalence of chronic diseases and rising demand for protein-rich diet.
Human serum albumin segment accounted for the largest share in the global albumin market in 2018, followed by bovine serum albumin and recombinant albumin segments. Human serum albumin segment accounted for the largest share in the global human serum albumin market due to its high demand as a therapeutic agent and its use as an ingredient in vaccines. Bovine serum albumin segment accounted for the second-largest share due to its high demand as a culture medium ingredient and its use as an ingredient in food products such as ice cream, cheese, yogurt, etc, which are rich sources of protein content. Recombinant human serum albumins are expected to witness significant growth during forecast period owing to their low cost compared with other types of human serums and their ability to be produced on large scale without any risk associated with animal-derived products or contamination risks associated with bacterial or viral agents that may be present in animal-derived products.
Some Of The Growth Factors Of This Market:
- The global Albumin market is expected to reach USD 3,890 million by 2025.
- Increasing prevalence of chronic diseases such as diabetes and cancer are driving the growth of the global Albumin market.
- Increasing awareness about the benefits of albumin therapy in various therapeutic areas such as oncology, cardiovascular diseases, and renal failure are also driving the growth of the global Albumin market.
- Growing demand for albumins in emerging economies such as China and India.
Industry Growth Insights published a new data on “Albumin Market”. The research report is titled “Albumin Market research by Types (Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin), By Applications (Therapeutics, Vaccine Ingredient, Culture Medium Ingredient, Other), By Players/Companies CSL, Grifols, Shire (Baxalta), Octapharma, Hualan Bio, CBPO, RAAS, Kedrion, Merck, LFB Group, Albumedix, Thermo Fisher Scientific”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Albumin Market Research Report
By Type
Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin
By Application
Therapeutics, Vaccine Ingredient, Culture Medium Ingredient, Other
By Companies
CSL, Grifols, Shire (Baxalta), Octapharma, Hualan Bio, CBPO, RAAS, Kedrion, Merck, LFB Group, Albumedix, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Albumin Market Report Segments:
The global Albumin market is segmented on the basis of:
Types
Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Therapeutics, Vaccine Ingredient, Culture Medium Ingredient, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CSL
- Grifols
- Shire (Baxalta)
- Octapharma
- Hualan Bio
- CBPO
- RAAS
- Kedrion
- Merck
- LFB Group
- Albumedix
- Thermo Fisher Scientific
Highlights of The Albumin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Human Serum Albumin
- Bovine Serum Albumin
- Recombinant Albumin
- By Application:
- Therapeutics
- Vaccine Ingredient
- Culture Medium Ingredient
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Albumin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Albumin is a protein found in the blood and other body tissues. It helps to carry oxygen and nutrients to the cells.
Some of the major companies in the albumin market are CSL, Grifols, Shire (Baxalta), Octapharma, Hualan Bio, CBPO, RAAS, Kedrion, Merck, LFB Group, Albumedix, Thermo Fisher Scientific.
The albumin market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Albumin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Albumin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Albumin Market - Supply Chain
4.5. Global Albumin Market Forecast
4.5.1. Albumin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Albumin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Albumin Market Absolute $ Opportunity
5. Global Albumin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Albumin Market Size and Volume Forecast by Type
5.3.1. Human Serum Albumin
5.3.2. Bovine Serum Albumin
5.3.3. Recombinant Albumin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Albumin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Albumin Market Size and Volume Forecast by Application
6.3.1. Therapeutics
6.3.2. Vaccine Ingredient
6.3.3. Culture Medium Ingredient
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Albumin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Albumin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Albumin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Albumin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Albumin Demand Share Forecast, 2019-2026
9. North America Albumin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Albumin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Albumin Market Size and Volume Forecast by Application
9.4.1. Therapeutics
9.4.2. Vaccine Ingredient
9.4.3. Culture Medium Ingredient
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Albumin Market Size and Volume Forecast by Type
9.7.1. Human Serum Albumin
9.7.2. Bovine Serum Albumin
9.7.3. Recombinant Albumin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Albumin Demand Share Forecast, 2019-2026
10. Latin America Albumin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Albumin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Albumin Market Size and Volume Forecast by Application
10.4.1. Therapeutics
10.4.2. Vaccine Ingredient
10.4.3. Culture Medium Ingredient
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Albumin Market Size and Volume Forecast by Type
10.7.1. Human Serum Albumin
10.7.2. Bovine Serum Albumin
10.7.3. Recombinant Albumin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Albumin Demand Share Forecast, 2019-2026
11. Europe Albumin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Albumin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Albumin Market Size and Volume Forecast by Application
11.4.1. Therapeutics
11.4.2. Vaccine Ingredient
11.4.3. Culture Medium Ingredient
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Albumin Market Size and Volume Forecast by Type
11.7.1. Human Serum Albumin
11.7.2. Bovine Serum Albumin
11.7.3. Recombinant Albumin
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Marke Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Albumin Demand Share, 2019-2026
12. Asia Pacific Albumin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Albumin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Albumin Market Size and Volume Forecast by Application
12.4.1. Therapeutics
12.4.2. Vaccine Ingredient
12.4.3. Culture Medium Ingredient
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Albumin Market Size and Volume Forecast by Type
12.7.1. Human Serum Albumin
12.7.2. Bovine Serum Albumin
12.7.3. Recombinant Albumin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Albumin Demand Share, 2019-2026
13. Middle East & Africa Albumin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Albumin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Albumin Market Size and Volume Forecast by Application
13.4.1. Therapeutics
13.4.2. Vaccine Ingredient
13.4.3. Culture Medium Ingredient
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Albumin Market Size and Volume Forecast by Type
13.7.1. Human Serum Albumin
13.7.2. Bovine Serum Albumin
13.7.3. Recombinant Albumin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Albumin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Albumin Market: Market Share Analysis
14.2. Albumin Distributors and Customers
14.3. Albumin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. CSL
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Grifols
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Shire (Baxalta)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Octapharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Hualan Bio
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. CBPO
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. RAAS
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Kedrion
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Merck
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. LFB Group
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Albumedix
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Thermo Fisher Scientific
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
